Marshall Wace’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,918
Closed -$269K 2693
2025
Q1
$269K Buy
+15,918
New +$269K ﹤0.01% 2181
2024
Q4
Sell
-33,777
Closed -$734K 2519
2024
Q3
$734K Buy
+33,777
New +$734K ﹤0.01% 1642
2024
Q1
Sell
-15,600
Closed -$451K 2248
2023
Q4
$451K Buy
15,600
+2,968
+23% +$85.8K ﹤0.01% 1462
2023
Q3
$338K Buy
12,632
+6,416
+103% +$172K ﹤0.01% 1549
2023
Q2
$230K Buy
+6,216
New +$230K ﹤0.01% 1788
2023
Q1
Sell
-6,900
Closed -$205K 2289
2022
Q4
$205K Sell
6,900
-49,109
-88% -$1.46M ﹤0.01% 2108
2022
Q3
$2.14M Buy
+56,009
New +$2.14M ﹤0.01% 1524
2022
Q1
Sell
-10,876
Closed -$1.09M 2822
2021
Q4
$1.09M Sell
10,876
-43,610
-80% -$4.39M ﹤0.01% 1875
2021
Q3
$4.9M Buy
54,486
+47,663
+699% +$4.29M 0.02% 831
2021
Q2
$629K Sell
6,823
-49,955
-88% -$4.61M ﹤0.01% 1582
2021
Q1
$5.49M Buy
56,778
+15,756
+38% +$1.52M 0.03% 710
2020
Q4
$2.14M Buy
+41,022
New +$2.14M 0.01% 837